KIMBERLY WALKER to Macrophages
This is a "connection" page, showing publications KIMBERLY WALKER has written about Macrophages.
Connection Strength
0.192
-
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UK. BMJ Open. 2024 Dec 09; 14(12):e089417.
Score: 0.164
-
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nat Cell Biol. 2019 09; 21(9):1113-1126.
Score: 0.028